Plasmids and siRNAs LAPTM4B mutants were generated by site-directed mutagenesis PCR using sequence-specific oligos (see Table S11 ). 3xFlag-tagged CD63 WT, LAPTM4A WT, LAPTM4B WT, and LAPTM4B mutant inserts were cloned into pEFIRES-P plasmid via EcoRI and XbaI sites 2 (kindly provided by Dr. Olli Ritvos). Cherry-tagged LAPTM4B was generated as described previously 1 . Constructs for FRET analysis were generated by cloning LAPTM4B WT or CD63 WT into pVenus-N1 plasmids using
XhoI/BamHI and BglII/SalI sites, respectively. 4F2hc was amplified by PCR from A431 cDNA and cloned into pCerulean-C1 vector using XhoI/BamHI sites. GFP-KDEL was kindly provided by Prof. Eija . The LAMP1-mGFP construct was obtained from Addgene (#34831) and has been originally generated by 4 . Detailed information about all constructs used in the study can be found in Table S11 .
SiRNAs against human LAPTM4B, SMPD1, and ASAH1 have been described previously 1 . SiRNA against human 4F2hc (SLC3A2; Ambion, Cat#4392420) is AGCUCAUACCUGUCUGAUUTT (sense).
All siRNAs were used at a final concentration of 10nM and cells were treated 2-3 days. For siRNA sequence details see Table S13 .
Cell culture A431 cells (ATCC, Cat#CRL-1555) and HeLa cells (ATCC, CAT#CCL-2) were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (FBS), penicillin, and streptomycin at 37 °C in 5% CO2. Cells were treated with 50mU/mL bacterial sphingomyelinase (Sigma, CAT#S-8633) for 30 minutes to generate ceramide. To assess mTORC1 activity, cells were starved for 1h with Earle's Balanced Salt Solution (EBSS), and subsequently refed with Stimulation Medium (EBSS:complete medium; 1:1) for different time points.
Generation of knockout cells and stable cell lines LAPTM4B A431 knockout cells were generated by CRISPR/Cas9-mediated genome engineering as described previously 5, 6 . Briefly, coding sequences in exon 3 of LAPTM4B (Gene ID: 55353) were selected and analyzed for the design of Cas9 nickase targets (http://crispr.mit.edu). sgRNA guides were synthesized and subcloned into the sgRNA expression vector using BbsI sites (see Table S11 ).
A431 cells were co-transfected with Cas9 nickase and two matching pairs of the sgRNA expressing plasmids using Lipofectamine LTX with PLUS reagent (Invitrogen, Cat#15338100), and subjected to puromycin (1µg/mL) selection for 48h post-transfection. Cells were further cultured in normal cell culture medium without puromycin for another 4 days. Subsequently, single clones were isolated and finally verified by Sanger sequencing. Cas9 nickase targets with effective knockout efficiency were used for this study and are shown in Figure S2A and S2B. As described previously 2 , for the generation of stable cell lines, A431 LAPTM4B knockout cells were transfected with pEFIRES-P plasmids containing either CD63 WT, LAPTM4A WT, LAPTM4B WT or mutant LAPTM4B (see Figure   S2C and S2D) using Lipofectamine LTX with PLUS reagent. Cells were grown in culture medium containing 1µg/mL puromycin until a resistant cell pool was formed. A431 cells stably expressing LAPTM4B WT or CD63 WT were generated as described 1 and were used for Co-IP and MS experiments in this study.
Quantitative PCR qPCR was performed as described previously 1 .
Western blot
Cells were washed with PBS, scraped in SDS boiling buffer (2.5% SDS, 250 mM Tris/HCl pH 6.8, including 50 mM NaF, 10 mM b-glycerophosphate, 0.5 mM DTT, 0.5 mM PMSF), and lysates were boiled at 98 o C for 10 minutes. Equal amounts of proteins were resolved on 12% Mini-Protean TGX Stain-Free gels (BioRad Cat#161-0185) and transferred onto LF-PVDF (BIORAD Cat#170-4274) or nitrocellulose membrane (BIORAD Cat#170-4270). Membranes were blocked with 5% milk in TBS containing 0.1% Tween-20 or Odyssey Blocking Buffer (LI-COR; Cat#927-40000) for 1h at room temperature, and subsequently probed with primary antibodies (Anti-Flag M2, 1:1,000 -1:2,000; anti-CD98 C-20, 1:1,000; Anti-phospho-p70 S6K, 1:1,000 -1:2,000, Anti-S6K After the pulldown, GFP-TRAP®_MA beads were washed two times with 1 mL cold fractionation buffer using a magnetic rack. LAMP1-mGFP-specific lysosomes were eluted with 50 µL SDS sample buffer per tube resulting in 100 µL of total eluate per sample. 10% of each sample were used for determining the total amount of protein for normalization. The remaining 90% of each sample were used for measuring the radioactivity by scintillation counting. Counts were normalized to total pulled down protein as the final measure of leucine lysosomal uptake.
Atomistic simulations
Peptide structure generation: The WALP23, LAPTM4B-TM3, LAPTM4B-TM3 D202A and LAPTM4B-TM4 peptides were created from their sequences (See Figure S1 ) using the Open Babel software.
The generated peptides were acetylated and amidated in their N-and C-terminal domains using the Avogadro software. The resulting peptides were then forced to establish a perfect alpha helix structure by restraining their phi and psi dihedral angles to -64 and -41 degrees during a molecular dynamics simulation of the peptides in the vacuum using force constant for these dihedrals of 1000 kJ mol -1 rad Tables S1-S3 ). Finally, we introduced Na + Cl -ions to neutralize any excess of charge and set the aqueous phase to a physiologically relevant salt concentration (150 mmol of Na system with the desired membrane as described in 12 . During this process, the peptides remain frozen.
After the successful insertion we equilibrate the system further using NPT (1 bar, 310 K) molecular dynamics simulations. In these simulations, we restrain not only the backbone dihedrals as discussed above but also the relative position of the peptides by applying a linear bias potential with force constant of -500 KJ/mol between the center of mass of the peptides. This last potential maximizes the inter-peptide distance prior the production runs. This process depending on the system lasted between 100 and 200 ns until the inter-peptide distance was stable and the area per molecule fluctuated around a defined average value. Finally, we performed a short equilibration simulation (20 ns) without any constraint prior the production runs. Other simulation parameters of the equilibration, not explicitly given here, are equal to those in the production runs described below.
Production runs: All simulated systems use Gromacs 5.1.X or 2016 13 using the charmm36 force field for the lipids (POPC and C16-ceramide) 14 and peptides (WALP23, LAPTM4B-TM3, LAPTM4B-TM3 D202A, and LAPTM4B-TM4) 15 . Few force field parameters missing for C16-ceramide were obtained from the CHARMMGUI 11 . Ions and water models used are the recommended ones by the force field.
All simulations used a time step of 2 fs, and the total simulation length varied between 1 to 2 microseconds per run. In most of the cases, several replicas of each system were generated. The total amount of simulation time of the project exceeds 70 microseconds. Simulation parameters used here are as provided by the CHARMM-GUI 11 . In brief, the NPT ensemble was provided by the ParrinelloRahman barostat 16 and the Nóse-Hoover thermostat 17, 18 . The time constants were set to 5 and 1 ps for the barostat and thermostat, respectively. The smooth PME scheme 19 was employed for electrostatics. The LJ interactions were cut off at 1.2 nm and the force switch modifier was employed from 1.0 nm on. The Verlet-type neighbor list was employed. The bonds connected to hydrogen atoms were constrained with the LINCS algorithm 20 .
Co-immunoprecipitation and mass spectrometry
The identification of LAPTM4B interaction partners was carried out by Reversible Cross-Link ImmunoPrecipitation (ReCLIP) 21 . Tandem Affinity Purification (TAP) was used to purify protein complexes followed by label-free protein quantitation with Mass Spectrometry. Briefly, single A431 clones overexpressing LAPTM4B or CD63 (as a negative control) with N-terminal 6His-Xpress and C-terminal 3XFlag tags were used 1 . Cells were cultured in complete medium or serum-free medium overnight.
Cells were crosslinked in vivo with 0.4 mM DTME (Thermo Scientific; #22335) and 0.1 mM LC-SPDP Precipitated proteins were finally resolved by SDS-PAGE and followed by label-free protein quantitation using MS (Proteomics Unit, Institute of Biotechnology, University of Helsinki).
Statistical analysis
All the data are presented as the mean ± standard error of mean (SEM) from at least three independent experiments. Statistical significance was calculated using the Student's t-test. The level of statistical significance was set at 0.05 for all the tests.
( (A) Control-or ASAH1-silenced LAPTM4B, or (B) ATM3 mutant cells were starved (1 h with EBSS), and pS6K expression was assessed by Western blotting upon refeeding with stimulation medium for the indicated time points. Left panels: representative experiments; right panels: quantifications of n = 3 experiments, mean ± SEM, differences are significant for p* < 0.05 compared to control.
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